The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation
- PMID: 10601262
- DOI: 10.1074/jbc.274.52.37046
The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation
Abstract
The bioactive phospholipid lysophosphatidic acid (LPA) causes growth cone collapse and neurite retraction in neuronal cells. These changes are brought about by the action of a cell surface receptor coupled to specific G proteins that control morphology and motility through the action of a group of small GTPases, the Rho family of proteins. Many studies have focused on actin reorganization modulated by Rho-GTPases, but almost no information has been obtained concerning microtubular network reorganization after LPA-induced neurite retraction. In the present study, we demonstrate an increase in site-specific Alzheimer's disease-like Tau phosphorylation during LPA-induced neurite retraction in differentiated SY-SH5Y human neuroblastoma cells. The phosphorylation state of Tau was inferred from its immunoreactivity with antibodies that recognize phosphorylation-sensitive epitopes. The effects of specific kinase inhibitors indicate that this phosphorylation is mediated by glycogen synthase kinase-3 (GSK-3). In support of this idea, we observed an increase of GSK-3 activity upon growth cone collapse. Our results are consistent with the hypothesis that activation of GSK-3 occurs in the Rho pathway and may represent an important link between microtubules and microfilaments dynamics during neuritogenesis and in pathological situations such as Alzheimer's disease.
Similar articles
-
Glycogen synthase kinase-3 is activated in neuronal cells by Galpha12 and Galpha13 by Rho-independent and Rho-dependent mechanisms.J Neurosci. 2002 Aug 15;22(16):6863-75. doi: 10.1523/JNEUROSCI.22-16-06863.2002. J Neurosci. 2002. PMID: 12177184 Free PMC article.
-
Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3β activation.Mol Cells. 2011 May;31(5):483-9. doi: 10.1007/s10059-011-1036-0. Epub 2011 Apr 14. Mol Cells. 2011. PMID: 21499833 Free PMC article.
-
Regulation of neuronal cytoskeleton by lysophosphatidic acid: role of GSK-3.Biochim Biophys Acta. 2002 May 23;1582(1-3):144-53. doi: 10.1016/s1388-1981(02)00149-x. Biochim Biophys Acta. 2002. PMID: 12069822 Review.
-
GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction.Mol Biol Cell. 2006 Apr;17(4):1834-44. doi: 10.1091/mbc.e05-07-0688. Epub 2006 Feb 1. Mol Biol Cell. 2006. PMID: 16452634 Free PMC article.
-
Tau therapeutic strategies for the treatment of Alzheimer's disease.Curr Top Med Chem. 2006;6(6):579-95. doi: 10.2174/156802606776743057. Curr Top Med Chem. 2006. PMID: 16712493 Review.
Cited by
-
A Promising Drug Candidate as Potent Therapeutic Approach for Neuroinflammation and Its In Silico Justification of Chalcone Congeners: a Comprehensive Review.Mol Neurobiol. 2024 Apr;61(4):1873-1891. doi: 10.1007/s12035-023-03632-0. Epub 2023 Oct 6. Mol Neurobiol. 2024. PMID: 37801205 Review.
-
The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer's Disease.Mol Neurobiol. 2023 Jul;60(7):3617-3632. doi: 10.1007/s12035-023-03277-z. Epub 2023 Mar 6. Mol Neurobiol. 2023. PMID: 36877359 Review.
-
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.Front Neurosci. 2022 Sep 1;16:970925. doi: 10.3389/fnins.2022.970925. eCollection 2022. Front Neurosci. 2022. PMID: 36117625 Free PMC article. Review.
-
Human Sensory Neuron-like Cells and Glycated Collagen Matrix as a Model for the Screening of Analgesic Compounds.Cells. 2022 Jan 12;11(2):247. doi: 10.3390/cells11020247. Cells. 2022. PMID: 35053363 Free PMC article.
-
G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-β in Alzheimer's disease.Mol Biomed. 2021 Jun 10;2(1):17. doi: 10.1186/s43556-021-00036-1. Mol Biomed. 2021. PMID: 35006431 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous